Virus isolation, polymerase chain reaction and in vitro antibody production for the diagnosis of pediatric human immunodeficiency virus infection.

Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Virus isolation, polymerase chain reaction and in vitro antibody production for the diagnosis of pediatric human immunodeficiency virus infection.

J Virol Methods. 1993 Apr;42(1):117-25. Unique Identifier : AIDSLINE MED/93308195
Garbarg-Chenon A; Segondy M; Conge AM; Huguet MF; Nicolas JC; Grimprel E; Moniot-Ville N; Bricout F; Serre A; Courpotin C; et al; Department of Microbiology and Pediatrics, Hopital Trousseau,; Paris, France.

Abstract: Viral culture (VC), polymerase chain reaction (PCR) and in vitro antibody production (IVAP) by peripheral blood mononuclear cells were compared for the early diagnosis of HIV-1 infection in 46 infants born to HIV-1 seropositive mothers. The ten children considered infected on the basis of clinical signs and persistence of anti-HIV-1 antibodies had at least one positive viral culture and seven were always positive in both PCR and IVAP tests. PCR and IVAP tests were occasionally negative in three infected children. Among 30 healthy children who became seronegative and were always negative for viral culture, 22 (73.3%) were also repeatedly negative in PCR and IVAP. We report 6 cases of children classified as P2A at the term of this study but who had lost anti-HIV-1 antibodies. They presented at least one positive viral culture and occasional positive PCR and/or IVAP results. The results indicate that the combination of viral culture, PCR and IVAP tests improves the early diagnosis of pediatric HIV infection.

Keywords: Antibody Formation Child, Preschool Comparative Study Female Follow-Up Studies Human HIV Antibodies/IMMUNOLOGY HIV Infections/*DIAGNOSIS/GENETICS/IMMUNOLOGY/TRANSMISSION HIV-1/GENETICS/IMMUNOLOGY/*ISOLATION & PURIF Infant Infant, Newborn Leukocytes, Mononuclear/IMMUNOLOGY Maternal-Fetal Exchange Polymerase Chain Reaction Pregnancy Prospective Studies Reproducibility of Results Time Factors JOURNAL ARTICLE
931030
M93A0704

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .